Present status and future prospects for adjuvant therapy of melanoma: time to build upon the foundation of high-dose interferon alfa-2b

J Clin Oncol. 2004 Jan 1;22(1):11-4. doi: 10.1200/JCO.2004.10.952. Epub 2003 Dec 9.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Biomarkers, Tumor
  • Chemotherapy, Adjuvant / trends
  • Dose-Response Relationship, Drug
  • Humans
  • Interferon-alpha / administration & dosage*
  • Interferon-alpha / therapeutic use*
  • Melanoma / drug therapy*
  • Melanoma / physiopathology
  • Melanoma / surgery
  • Prognosis
  • Randomized Controlled Trials as Topic
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / physiopathology
  • Skin Neoplasms / surgery

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Interferon-alpha